Assignee
SHANGHAI HUAOTA BIOPHARMACEUTICAL CO LTD
CN·0 granted patents·8 pending applications·0 citations·filing 2021–2023
Top patents by PatentIndex Score
8 records- 0160US2025195679A1Antibody-drug conjugate and use thereofSHANGHAI HUAOTA BIOPHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 0259US2025361314A1Cd39/cd73 bispecific antigen binding protein and use thereofSHANGHAI HUAOTA BIOPHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 0355US2024026004A1ANTI-PD-L1/TGF-ß BIFUNCTIONAL ANTIBODY AND USE THEREOFSHANGHAI HUAOTA BIOPHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
- 0451US2024026024A1Cd73 antigen-binding protein and application thereofSHANGHAI HUAOTA BIOPHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
- 0550US2025074988A1Pd-l1 antigen binding protein and use thereofSHANGHAI HUAOTA BIOPHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 0647US2024010730A1Bispecific antibody and use thereofSHANGHAI HUAOTA BIOPHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
- 0742US2023399409A1Antibody targeting interleukin 36r, preparation method therefor, and application thereofSHANGHAI HUAOTA BIOPHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
- 0841US2024067747A1Cd73-binding protein and use thereofSHANGHAI HUAOTA BIOPHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when SHANGHAI HUAOTA BIOPHARMACEUTICAL CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →